Friday, September 28, 2018

ChemoCentryx terminates previously announced common stock offering


ChemoCentryx (NASDAQ:CCXI) will not conclude previously announced common stock offering.
The Company believes that culmination of terms representing the best interests of its stockholders is not to be achieved at the current time.
Shares are up 11% premarket.
Previously: ChemoCentryx launches $75M stock offering (Sept. 26)
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.